Cerebral ischemia-reperfusion injury: A novel therapeutic approach with TAK-218

Clinical Neuropharmacology

Volumn 23, Issue 2, 2000, Pages 69-74

  Solenski, Nina J ^a   DiPierro, Charles G ^a   Kassell, Neal F ^a   Helm, Gregory A ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Cerebral ischemia; Neuroprotection; Rat; Reperfusion

Indexed keywords

2,3 DIHYDRO 2,4,6,7 TETRAMETHYL 2 [(4 PHENYL 1 PIPERIDINYL)METHYL] 5 BENZOFURANAMINE; NEUROPROTECTIVE AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN ISCHEMIA; CONTROLLED STUDY; DOPAMINE RELEASE; DRUG EFFECT; LIPID PEROXIDATION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; BENZOFURANS; BLOOD GAS ANALYSIS; HEMODYNAMIC PROCESSES; ISCHEMIC ATTACK, TRANSIENT; MALE; NEUROPROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY;

EID: 0034000990     PISSN: 03625664     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002826-200003000-00002     Document Type: Article

References (53)

1. Ohkawa S, Fukatsu K, Miki S, et al. 5-aminocoumarans: dual inhibitors of lipid peroxidation and dopamine release with protective effects against central nervous system trauma and ischemia. J Med Chem 1997;40:559-73.
2. Kucharczyk J, Mintorovitch J, Moseley ME, et al. Ischemic brain damage reduction by sodium-calcium ion channel modulator RS-87476. Radiology 1991;179:221-7.
3. + channels are targets for neuroprotective drugs. Trends Pharmacol Sci 1998;16:309-16.
4. Brown CM, Calder C, Alps BJ, Speeding M. The effect of lifarizine (RS-87476), a novel sodium and calcium channel modulator, on ischaemic dopamine depletion in the corpus striatum of the gerbil. Br J Pharmacol 1993;109:175-7.
5. Graham SH, Chen J, Lan J, Leach MJ, Simon RP. Neuroprotective effects of a use-dependent blocker of voltage-dependent sodium channels, BW619C89. J Pharmacol Exp Ther 1994;230:854-9.
6. Meldrum BS, Swan JH, Leach MJ, et al. Reduction of glutamate release and protection against ischemic brain damage by BW 1003C87. Brain Res 1992;593:1-6.
7. Smith SE, Meldrum BS. Cerebroeffective effect of of lamotrigine after focal ischemia in rats. Stroke 1995;26:117-22.
8. Taft WC, Clifton GL, Blair RE, Delorenzo RJ. Phenytoin protects against ischemia-produced neuronal cell death. Brain Res 1998;483: 143-8.
9. Wahl F, Allix M, Plotkine M, Boulu R. Effect of riluzole of focal cerebral ischemia in rats. Eur J Pharmacol 1993;230:209-14.
10. Wiard RP, Dickerson MC, Beek O, Norton R, Cooper BR. Neuroprotective properties of the novel antiepiletic lamotrigine in a gerbil model of global cerebral ischemia. Stroke 1995;26:26-46.
11. Chan PH, Yurko M, Fishman RA. Phospholipid degradation and cellular edema induced by free radicals in brain cortical slices. J Neurochem 1982;38:525-31.
12. Chan PH. Role of oxidants in ischemic brain damage. Stroke 1996; 27:1124-9.
13. Hall ED, Braughler JM. Free radicals in CNS injury. Res Publications - Association Res Nerv Ment Dis 1993;71:81-105.
14. Kinuta Y, Kikuchi H, Ishikawa M, Kimura M, Itokawa Y. Lipid peroxidation in focal cerebral ischemia. J Neurosurg 1989;71: 421-9.
15. Sakamoto A, Ohnishi ST, Ohnishi T, Ogawa R. Relationship between free radical production and lipid peroxidation during ischemia-reperfusion injury in the rat brain. Brain Res 1991;554:186-92.
16. Hall ED, McCall JM, Means ED. Therapeutic potential of the lazaroids (21-aminosteriods) in CNS trauma, ischemia and subarachnoid hemorrhage. Adv Pharmacol 1994;28:221-68.
17. Hall ED. Inhibition of lipid peroxidation in central nervous system trauma and ischemia. J Neurol Sci 1995;134:79-83.
18. Hall ED, Andrus PK, Smith SL, et al. Neuroprotective efficacy of microvascularly-localized versus brain-penetrating antioxidants. Acta Neurochir Suppl 1996;66:107-33.
19. Xue D, Slivka A, Buchan AM. Tirilazad reduces cortical infarction after transient but not permanent focal cerebral ischemia in rats. Stroke 1992;23:894-9.
20. Pellegrini-Giampietro DE, Cherici G, Alesiani M, Carla V, Moroni F. Excitatory amino acid release and free radical formation may cooperate in the genesis of ischemia-induced neuronal death. J Neurosci 1990;10:1035-41.
21. Anonymous. A randomized trial of tirilazad mesylate in patients with acute stroke (RANTTAS). The RANTTAS Investigators. Stroke 1996;28:1453-88.
22. Clark WM, Hazel JS, Coull BM. Lazaroids: CNS pharmacology and current research. Drugs 1995;50:971-83.
23. Bralet J, Beley P, Bralet AM, Beley A. Catecholamine levels and turnover during brain ischemia in the rat. J Neural Transm 1980;48: 143-55.
24. Gustafson I, Westerberg EJ, Wieloch T. Extracellular brain cortical levels of noradrenaline in ischemia: effects of desipramine and post-ischemic administration of idazoxan. Exp Brain Res 1991;86:555-611.
25. Blomqvist P, Lindvall O, Stenevi U, Wieloch T. Cyclic AMP concentrations in rat neocortex and hippocampus during and following incomplete ischemia: effects of central noradrenergic neurons, prostaglandins, and adenosine. J Neurochem 1985;44:1345-53.
26. Richards DA, Obrenovitch TP, Symon L, Curzon G. Extracellular dopamine and serotonin in the rat striatum during transient ischaemia of different severities: a microdialysis study. J Neurochem 1993;60:128-36.
27. Wurtman RJ, Zervas NT. Monoamine neurotransmitters and the pathophysiology of stroke and central nervous system trauma. J Neurosurg 1974;40:34-6.
28. MacKenzie ET, Lacombe PM. Catecholamines and their receptors. In: Welch KMA, Caplan LR, Reis DJ, Siesjo BK, Weir B, eds. Primer on cerebrovascular diseases. San Diego, CA: Academic Press; 1997;86-91.
29. Catecholaminergic innervation of cerebral blood vessels. In: Harik SI, Phillis JW, eds. The regulation of cerebral blood flow. Boca Raton, FL: CRC Press; 1993.
30. Chen ST, Hsu CY, Hogan EL, Maricq H, Balentine JD. A model of focal ischemic stroke in the rat: reproducible extensive cortical infarction. Stroke 1986;17:738-43.
31. Hiramatsu K, Kassell NF, Goto Y, Lee KS. A reproducible model of reversible, focal, neocortical ischemia in Sprague-Dawley rat. Acta Neurochir 1993;120:66-71.
32. Goto Y, Kassell NF, Hiramatsu K, Soleau SW, Lee KS. Effects of intraischemic hypothermia on cerebral damage in a model of reversible focal ischemia. Neurosurgery 1993;32:980-4.
33. Goto Y, Kassell NF, Hiramatsu K, Hong SC, Soleau SW, Lee KS. Effects of two dual-function compounds, U92798 and U92032, on transient focal ischemia in rats. Neurosurgery 1994;34:332-7.
34. Hong SC, Lanzino G, Goto Y, et al. Calcium-activated proteolysis in rat neocortex induced by transient focal ischemia. Brain Res 1994;661:43-50.
35. Hong SC, Goto Y, Lanzino G, Soleau S, Kassell NF, Lee KS. Neuroprotection with a calpain inhibitor in a model of focal cerebral ischemia. Stroke 1994;25:663-9.
36. Solenski NJ, Kwan AL, Yanamoto H, Bennett JP, Kassell NF, Lee KS. Differential hydroxylation of salicylate in core and penumbra regions during focal reversible cerebral ischemia. Stroke 1997;28: 2545-51.
37. Toyoda T, Suzuki S, Kassell NF, Lee KS. Intraischemic hypothermia attenuates neutrophil infiltration in the rat neocortex after focal ischemia-reperfusion injury. Neurosurgery 1996;39:1200-5.
38. Toyoda T, Lee KS. Differential induction of superoxide dismutase in core and penumbra regions after transient focal ischemia in the rat neocortex. Neurosci Lett 1997;10:29-32.
39. Toyoda T, Kassell NF, Lee KS. Attenuation of ischemia-reperfusion injury in the rat neocortex by the hydroxyl radical scavanger nicaraven. Neurosurgery 1997;40:372-7.
40. Yanamoto H, Hong SC, Soleau S, Kassell NF, Lee KS. Mild postischemic hypothermia limits cerebral injury following transient focal ischemia in rat neocortex. Brain Res 1996;718:207-11.
41. Brannan T, Weinberger J, Knott P, et al. Direct evidence of acute, massive striatal dopamine release in gerbils with unilateral strokes. Stroke 1987;18:108-10.
42. Kawano T, Tsutsumi K, Miyake H, Mori K. Striatal dopamine in acute cerebral ischemia of stroke-resistant rats. Stroke 1988;19: 1540-3.
43. Shirotani T, Shima K, Chigasaki H. In vivo studies of extracellular metabolites in the striatum after distal middle cerebral artery occlusion in stroke-prone spontaneously hypertensive rats. Stroke 1995; 26:878-84.
44. Toner CC, Stamford JA. 'Real time' measurement of dopamine release in an in vitro model of neostriatal ischaemia. J Neurosci Methods 1996;67:133-40.
45. Gustafson I, Westerberg E, Wieloch T. Protection against ischemia-induced neuronal damage by the alpha 2-adrenoceptor antagonist idazoxan: influence of time of administration and possible mechanisms of action. J Cereb Blood Flow Metab 1990;10:885-94.
46. Kozuka M, Iwata N. Changes in levels of monoamines and their metabolites in incompletely ischemic brains of spontaneously hypertensive rats. Neurochem Res 1995;20:1429-35.
47. Matsumoto M, Kimura K, Fujisawa A, et al. Differential effect of cerebral ischemia on monoamine content of discrete brain regions of the Mongolian gerbil (Meriones unguiculatus). J Neurochem 1984; 42:647-51.
48. Meyer JS, Miyakawa Y, Welch KM, et al. Influence of adrenergic receptor blockade on circulatory and metabolic effects of disordered neurotransmitter function in stroke patients. Stroke 1976;7: 158-67.
49. Miyauchi Y, Wieloch T, Lindvall O. Noradrenaline metabolism in neocortex and hippocampus following transient forebrain ischemia in rats: relation to development of selective neuronal necrosis. J Neurochem 1989;53:408-15.
50. Smith KE, Hachinski VC, Gibson CJ, Ciriello J. Changes in plasma catecholamine levels after insula damage in experimental stroke. Brain Res 1986;375:182-5.
51. Weinberger J, Nieves-Rosa J. Monoamine neurotransmitters in the evolution of infarction in ischemic striatum: morphologic correlation. J Neural Transm 1988;71:133-42.
52. Delbarre B, Delbarre G, Rochat C, Calinon F. Effect of piribedil, a D-2 dopaminergic agonist, on dopamine, amino acids, and free radicals in gerbil brain after cerebral ischemia. Mol Chem Neuropathol 1995;26:43-52.
53. Dawson VL, Hsu CY, Liu TH, Dawson TM, Wamsley JK. Receptor alterations in subcortical structures after bilateral middle cerebral artery infarction of the cerebral cortex. Exp Neurol 1994;128:88-96.